Immune system variation can predict severe COVID-19 outcomes
On Jul. 27, 2020, Yale university researchers reported that differing immune system responses of patients with COVID-19 can…
-
-
NIH invested $58 million to catalyze data science and health research innovation in Africa
On Jul. 27, 2020, the National Institutes of Health (NIH) launched a $58 million initiative to advance data…
-
Phase 3 clinical trial of investigational vaccine for COVID-19 began
On Jul. 27, 2020, the National Institutes of Health (NIH) announced that a phase 3 clinical trial designed…
-
Amyris and the Infectious Disease Research Institute partnered to advance novel RNA vaccine platform beginning with COVID-19 application
On Jul. 27, 2020, Amyris and the Infectious Disease Research Institute (IDRI) announced the signing of a Collaboration…
-
Emergent BioSolutions signed agreement with AstraZeneca to expand manufacturing for COVID-19 Vaccine candidate
On Jul. 27, 2020, Emergent BioSolutions announced that it had signed an agreement to provide contract development and…
-
MediciNova announced SARS-CoV-2 vaccine joint development with BioComo and Mie University Japan
On Jul. 27, 2020, MediciNova announced an agreement with BioComo and Mie University (Mie prefecture, Japan) for joint…
-
Moderna announced phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273) began
On Jul. 27, 2020, Moderna announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against…
-
Todos Medical announced SARS-nCoV-19 testing kit contract with NJ-based best supply clinical laboratory
On Jul. 27, 2020, Todos Medical announced the Company has entered into a contract to supply NJ-based laboratory…
-
Immunic announced first patients enrolled in investigator-sponsored phase 2 clinical trial of IMU-838 in combination with Oseltamivir for treatment of patients with COVID-19
On Jul. 27, 2020, Immunic announced enrollment of the first patients in an investigator-sponsored phase 2 clinical trial…
-
NIH awarded $9.5 million for Einstein-Mount Sinai Diabetes Research Center
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
-
Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
-
Moderna announced expansion of BARDA agreement to support larger phase 3 program for vaccine (mRNA-1273) against COVID-19
On Jul. 26, 2020, Moderna announced a modification to its contract with the Biomedical Advanced Research and Development…
-
LabCorp received authorization for COVID-19 sample pooling
On Jul. 25, 2020, LabCorp announced it received an Emergency Use Authorization from the FDA permitting diagnostic testing…
-
Biotechnology | Clinical Research | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
CIRM board approved two new discovery research projects for COVID-19
On Jul. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
Dynavax and Medigen announced collaboration to develop a novel adjuvanted COVID-19 vaccine candidate
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics announced their collaboration to develop an adjuvanted vaccine…
-
Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidate
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
-
AXIM Biotechnologies released Rapid NeuCovix test results showing strong agreement with COVID-19-based neutralization tests
On Jul. 23, 2020, AXIM Biotechnologies announced the completion of a study highlighting the performance of NeuCovix™, AXIM’s…
-
CDC released new resources and tools to support opening schools
On Jul. 23, 2020, the Centers for Disease Control and Prevention (CDC) released new science-based resources and tools…
-
Intravacc and Leiden University developed an animal replacement method for vaccines
On Jul. 23, 2020, Intravacc announced the publication of a study in Scientific Reports on alternatives to the…
-
Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19
On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…
-
NIH leadership detailed unprecedented initiative to ramp up testing technologies for COVID-19
On Jul. 22, 2020, In a paper in the New England Journal of Medicine, scientific leaders from the…
-
RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and Mexico
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
-
COVID-19 antibodies decay quickly after mild illness
On Jul. 22, 2020, University of California at Los Angeles researchers reported that they found. levels of antibodies…
-
COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response
On Jul. 22, 2020, the World Health Organization (WHO) and UNICEF announced the COVID-19 Law Lab initiative which…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Vaccine
University of British Columbia scientists sequence genomes of Canadians with COVID-19
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…
-
Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVID single dose intranasal vaccine candidate for COVID-19
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmune’s single-dose intranasal vaccine…
-
Biotechnology | Diagnostics | FDA | Oncology
BD received FDA approval for HPV test with extended genotyping capabilities
On Jul. 22, 2020, BD (Becton, Dickinson) announced that it had received approval for a pre-market approval (PMA)…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
-
A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment
On Jul. 22, 2020, a study led by Albert Einstein College of Medicine and Montefiore Health System confirmed…
-
Experimental coronavirus vaccine reported safe and produces immune response
On Jul. 21, 2020, researchers announced they were working to develop a safe and effective vaccine against SARS-CoV-2,…
